Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Topics & Concepts
MedicineMeta-analysisInternal medicineDipeptidyl peptidase-4MetforminOdds ratioDipeptidyl peptidase-4 inhibitorVildagliptinRandomized controlled trialGastroenterologyRetrospective cohort studyDiabetes mellitusType 2 diabetesEndocrinologyInsulinPeptidase Inhibition and AnalysisPancreatitis Pathology and TreatmentDiabetes Treatment and Management